85 related articles for article (PubMed ID: 15065764)
21. Immune functions encoded by the natural killer gene complex.
Yokoyama WM; Plougastel BF
Nat Rev Immunol; 2003 Apr; 3(4):304-16. PubMed ID: 12669021
[TBL] [Abstract][Full Text] [Related]
22. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.
Lenac T; Budt M; Arapovic J; Hasan M; Zimmermann A; Simic H; Krmpotic A; Messerle M; Ruzsics Z; Koszinowski UH; Hengel H; Jonjic S
J Exp Med; 2006 Aug; 203(8):1843-50. PubMed ID: 16831899
[TBL] [Abstract][Full Text] [Related]
23. NKG2D and cytotoxic effector function in tumor immune surveillance.
Hayakawa Y; Smyth MJ
Semin Immunol; 2006 Jun; 18(3):176-85. PubMed ID: 16675266
[TBL] [Abstract][Full Text] [Related]
24. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.
Kaiser BK; Yim D; Chow IT; Gonzalez S; Dai Z; Mann HH; Strong RK; Groh V; Spies T
Nature; 2007 May; 447(7143):482-6. PubMed ID: 17495932
[TBL] [Abstract][Full Text] [Related]
25. Cancer immunosurveillance: NKG2D breaks cover.
Ljunggren HG
Immunity; 2008 Apr; 28(4):492-4. PubMed ID: 18400193
[TBL] [Abstract][Full Text] [Related]
26. Innate immune recognition and suppression of tumors.
Hayakawa Y; Smyth MJ
Adv Cancer Res; 2006; 95():293-322. PubMed ID: 16860661
[TBL] [Abstract][Full Text] [Related]
27. NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice.
Zhou R; Wei H; Sun R; Zhang J; Tian Z
Proc Natl Acad Sci U S A; 2007 May; 104(18):7512-5. PubMed ID: 17463084
[TBL] [Abstract][Full Text] [Related]
28. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
[TBL] [Abstract][Full Text] [Related]
29. BCR/ABL promotes dendritic cell-mediated natural killer cell activation.
Terme M; Borg C; Guilhot F; Masurier C; Flament C; Wagner EF; Caillat-Zucman S; Bernheim A; Turhan AG; Caignard A; Zitvogel L
Cancer Res; 2005 Jul; 65(14):6409-17. PubMed ID: 16024645
[TBL] [Abstract][Full Text] [Related]
30. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
Song H; Kim J; Cosman D; Choi I
Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
[TBL] [Abstract][Full Text] [Related]
31. MIC and other NKG2D ligands: from none to too many.
Bahram S; Inoko H; Shiina T; Radosavljevic M
Curr Opin Immunol; 2005 Oct; 17(5):505-9. PubMed ID: 16087327
[TBL] [Abstract][Full Text] [Related]
32. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?
Zhang C; Zhang J; Wei H; Tian Z
Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316
[TBL] [Abstract][Full Text] [Related]
33. The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition.
Sullivan LC; Clements CS; Beddoe T; Johnson D; Hoare HL; Lin J; Huyton T; Hopkins EJ; Reid HH; Wilce MC; Kabat J; Borrego F; Coligan JE; Rossjohn J; Brooks AG
Immunity; 2007 Dec; 27(6):900-11. PubMed ID: 18083576
[TBL] [Abstract][Full Text] [Related]
34. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide.
Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD
J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537
[TBL] [Abstract][Full Text] [Related]
35. NK cells and cancer immunosurveillance.
Waldhauer I; Steinle A
Oncogene; 2008 Oct; 27(45):5932-43. PubMed ID: 18836474
[TBL] [Abstract][Full Text] [Related]
36. Comparison of level of NKG2D ligands between normal and tumor tissue using multiplex RT-PCR.
Park SW; Bae JH; Kim SD; Son YO; Kim JY; Park HJ; Lee CH; Park DY; Kim JY; Lee MK; Chung BS; Kim SH; Kang CD
Cancer Invest; 2007 Aug; 25(5):299-307. PubMed ID: 17661204
[TBL] [Abstract][Full Text] [Related]
37. Structural and energetic aspects of multispecific immune recognition by NKG2D.
O'Callaghan CA; Jones EY
Structure; 2003 Apr; 11(4):360-1. PubMed ID: 12679010
[No Abstract] [Full Text] [Related]
38. Molecular characterization of two novel alternative spliced variants of the KLRF1 gene and subcellular distribution of KLRF1 isoforms.
Roda-Navarro P; Hernanz-Falcón P; Arce I; Fernández-Ruiz E
Biochim Biophys Acta; 2001 Aug; 1520(2):141-6. PubMed ID: 11513955
[TBL] [Abstract][Full Text] [Related]
39. [Structures and action mechanisms of receptors for lipid mediators].
Watanabe T
Tanpakushitsu Kakusan Koso; 1992 May; 37(6):925-36. PubMed ID: 1320283
[No Abstract] [Full Text] [Related]
40. CD32 (Fc gammaRII).
Zola H; Jessup C; Nicholson IC; Macardle PJ
J Biol Regul Homeost Agents; 2000; 14(4):311-6. PubMed ID: 11215828
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
